StonvexLoading…
StonvexStonvexStonvexCore line items from NFG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-09-30 | Annual 2024 2024-09-30 | Annual 2023 2023-09-30 | Annual 2022 2022-09-30 |
|---|---|---|---|---|
Revenue | $2.22B | $1.71B | $2.25B | $3.06B |
Operating Income | $813.46M | $209.72M | $755.15M | $814.52M |
Net Income | $518.50M | $77.51M | $476.87M | $566.02M |
EPS (Diluted) | $5.68 | $0.84 | $5.17 | $6.15 |
Total Assets | $8.72B | $8.32B | $8.28B | $7.90B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $43.17M | $38.22M | $55.45M | $46.05M |
Free Cash Flow OCF − CapEx | $187.21M | $134.72M | $227.21M | $695.00K |
Shares Outstanding | 90.38M | 91.01M | 91.82M | 91.48M |